These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23094830)

  • 1. Potential applications of vasoactive intestinal Peptide-based therapies on transplantation.
    Souza-Moreira L; Delgado-Maroto V; Delgado M
    Endocr Metab Immune Disord Drug Targets; 2012 Dec; 12(4):333-43. PubMed ID: 23094830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
    Pozo D; Gonzalez-Rey E; Chorny A; Anderson P; Varela N; Delgado M
    Peptides; 2007 Sep; 28(9):1833-46. PubMed ID: 17521775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
    Chorny A; Gonzalez-Rey E; Delgado M
    Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D; Anderson P; Gonzalez-Rey E
    J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
    Gonzalez-Rey E; Anderson P; Delgado M
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.
    Delgado M; Chorny A; Ganea D; Gonzalez-Rey E
    Ann N Y Acad Sci; 2006 Jul; 1070():226-32. PubMed ID: 16888171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
    Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.
    Ganea D; Hooper KM; Kong W
    Acta Physiol (Oxf); 2015 Feb; 213(2):442-52. PubMed ID: 25422088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.
    Prasse A; Zissel G; Lützen N; Schupp J; Schmiedlin R; Gonzalez-Rey E; Rensing-Ehl A; Bacher G; Cavalli V; Bevec D; Delgado M; Müller-Quernheim J
    Am J Respir Crit Care Med; 2010 Aug; 182(4):540-8. PubMed ID: 20442436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis.
    Gonzalez-Rey E; Delgado M
    Trends Mol Med; 2007 Jun; 13(6):241-51. PubMed ID: 17467339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the alloresponse: new approaches to graft-versus-host disease prevention.
    Teshima T; Ferrara JL
    Semin Hematol; 2002 Jan; 39(1):15-22. PubMed ID: 11799525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application.
    Kato K; Takeuchi A; Akashi K; Eto M
    Front Immunol; 2019; 10():3138. PubMed ID: 32082305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.
    Delgado M; Abad C; Martinez C; Juarranz MG; Arranz A; Gomariz RP; Leceta J
    J Mol Med (Berl); 2002 Jan; 80(1):16-24. PubMed ID: 11862320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Martin J; Pozo D; Ganea D; Delgado M
    Am J Pathol; 2006 Apr; 168(4):1179-88. PubMed ID: 16565493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.